[
  {
    "ts": null,
    "headline": "McKesson : Q2 2025 McKesson Corporation Earnings Conference Call Transcript",
    "summary": "Corrected Transcript 06-Nov -2024 McKesson Corp. Q2 2025 Earnings Call ...",
    "url": "https://finnhub.io/api/news?id=7e8cb2e43c7f529e343cd24a078f901f8c71c35fc4569e5b4e4b59f91bdede6e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731164943,
      "headline": "McKesson : Q2 2025 McKesson Corporation Earnings Conference Call Transcript",
      "id": 131253563,
      "image": "",
      "related": "MCK",
      "source": "Finnhub",
      "summary": "Corrected Transcript 06-Nov -2024 McKesson Corp. Q2 2025 Earnings Call ...",
      "url": "https://finnhub.io/api/news?id=7e8cb2e43c7f529e343cd24a078f901f8c71c35fc4569e5b4e4b59f91bdede6e"
    }
  },
  {
    "ts": null,
    "headline": "McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network",
    "summary": "We rate McKesson as a 'Strong Buy' with focus on GLP-1 meds, oncology network, and strong Q2 results driving future growth. Read more on MCK stock here.",
    "url": "https://finnhub.io/api/news?id=3ae01ea4923ff3c57e62125f3823dc7d27cbe80cd68f133b68dead7486b44513",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731117000,
      "headline": "McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network",
      "id": 131242612,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1689238066/image_1689238066.jpg?io=getty-c-w1536",
      "related": "MCK",
      "source": "SeekingAlpha",
      "summary": "We rate McKesson as a 'Strong Buy' with focus on GLP-1 meds, oncology network, and strong Q2 results driving future growth. Read more on MCK stock here.",
      "url": "https://finnhub.io/api/news?id=3ae01ea4923ff3c57e62125f3823dc7d27cbe80cd68f133b68dead7486b44513"
    }
  }
]